Monitor for upcoming index inclusion announcements or changes in ELDN's index eligibility, as the buying pattern aligns with passive rebalancing. While the cluster shows increased institutional interest, the lack of active manager participation limits the strength of the bullish signal. A follow-up filing showing active fund involvement would strengthen the thesis.
Executive Summary
Three major passive institutions — Morgan Stanley, Schwab, and UBS — significantly increased their positions in Eledon Pharmaceuticals (ELDN) during Q4 2024, collectively adding $1.9M in new holdings. All three funds doubled their positions, with UBS making the most substantial move by increasing its stake from just 4 shares to 318.6K shares, now valued at $1.3M. This coordinated accumulation suggests growing institutional interest in the small-cap biotech, though all buyers are passive managers, indicating potential index-related rebalancing rather than active conviction.
Key Financial Metrics
Institutional Positions
Net institutional flow: $1.9M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | DOUBLED | +109.1% | $719.0K | $511.0K |
| Schwab | DOUBLED | +100.1% | $124.0K | $86.0K |
| UBS | DOUBLED | +7964425% | $1.3M | $1.3M |
Key Facts
- Morgan Stanley doubled its position: 83.5K → 174.5K shares, value increased by $511K to $719K
- Schwab doubled its position: 15.0K → 30.0K shares, value increased by $86K to $124K
- UBS dramatically increased its stake: from 4 to 318.6K shares, value surged from $10 to $1.3M (Δ+$1.3M)
- No institutional selling observed in the quarter
- All buyers are mega-passive firms, suggesting possible index inclusion or rebalancing
Financial Impact
Three institutions accumulated $1.9M in new positions with no offsetting sales
Risk Factors
- Passive buying may not reflect fundamental conviction and could reverse on index changes
- Limited float impact if total shares acquired represent a small fraction of outstanding shares
- No insider or active hedge fund participation to validate the move
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-ELDN-2024-Q4 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 22, 2026 4w ago | Institutional Cluster | $2.89 $2.26 | ▼ −21.97% | ▼ −21.41% | — |
Sep 22, 2026 5w ago | Press Release | $2.89 $2.26 | ▼ −21.97% | ▼ −21.41% | — |
May 20, 2026 22w ago | Press Release | $3.89 $3.82 | ▼ −1.93% | ▼ −2.26% | — |
Mar 10, 2026 33w ago | Press Release | $2.90 $3.13 | ▲ +7.93% | ▲ +8.09% | — |
Feb 28, 2026 34w ago | Institutional Cluster | $2.66 $2.71 | ▲ +1.88% | ▲ +9.82% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers